SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 479.89 |
| Enterprise Value ($M) | 440.69 |
| Book Value ($M) | 39.13 |
| Book Value / Share | 0.19 |
| Price / Book | 12.26 |
| NCAV ($M) | -14.00 |
| NCAV / Share | -0.07 |
| Price / NCAV | -34.28 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.02 |
| Return on Assets (ROA) | -0.61 |
| Return on Equity (ROE) | -1.00 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.35 |
| Current Ratio | 1.35 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 58.13 |
| Assets | 111.26 |
| Liabilities | 72.13 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 4.60 | 0.00 | |
| 13G/A | Biogen Inc. | 1.60 | -77.82 | |
| 13G/A | BlackRock, Inc. | 2.30 | -66.64 | |
| 13G/A | Wasatch Advisors Inc | |||
| 13G/A | State Street Corp | 1.53 | -72.33 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 459,499 | 2,720,029 | 16.89 | |
| 973,926 | 4,846,326 | 20.10 | |
| 1,522,559 | 7,850,434 | 19.39 | |
| 857,671 | 4,242,165 | 20.22 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SAVA – Cassava Sciences, Inc. | SBFM – Sunshine Biopharma, Inc. |
| SCLX – Scilex Holding Company | SHPH – Shuttle Pharmaceuticals Holdings, Inc. |
| SILO – Silo Pharma, Inc. |